Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 2 The differences in recurrence or survival rate between the low and high Treg percentage groups

From: An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy

 

Low (N = 51)

High (N = 26)

p-value

Recurrence.within.6.months

   

 No

48 (94.1%)

11 (42.3%)

< 0.001

 Yes

3 (5.9%)

15 (57.7%)

 

Recurrence.within.12.months

   

 No

43 (84.3%)

10 (38.5%)

< 0.001

 Yes

8 (15.7%)

16 (61.5%)

 

Recurrence.within.24.months

   

 No

41 (80.4%)

7 (26.9%)

< 0.001

 Yes

10 (19.6%)

19 (73.1%)

 

Recurrence

   

 No

35 (68.6%)

6 (23.1%)

< 0.001

 Yes

16 (31.4%)

20 (76.9%)

 

Status

   

 Alive at last follow-up

39 (76.5%)

13 (50.0%)

0.019

 Died

12 (23.5%)

13 (50.0%)

 
  1. Abbreviations: Treg, regulatory T cells
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us